Zurich Cantonal Bank’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.4K | Sell |
663
-73
| -10% | -$1.37K | ﹤0.01% | 2506 |
|
|
2025
Q1 | $13.2K | Buy |
+736
| New | +$13.2K | ﹤0.01% | 2574 |
|
|
2022
Q4 | – | Sell |
-2,669
| Closed | -$31K | – | 2894 |
|
|
2022
Q3 | $31K | Hold |
2,669
| – | – | ﹤0.01% | 2722 |
|
|
2022
Q2 | $30K | Hold |
2,669
| – | – | ﹤0.01% | 2727 |
|
|
2022
Q1 | $80K | Sell |
2,669
-1,577
| -37% | -$47.3K | ﹤0.01% | 2375 |
|
|
2021
Q4 | $113K | Sell |
4,246
-159
| -4% | -$4.23K | ﹤0.01% | 2442 |
|
|
2021
Q3 | $160K | Buy |
4,405
+51
| +1% | +$1.85K | ﹤0.01% | 2068 |
|
|
2021
Q2 | $189K | Buy |
4,354
+826
| +23% | +$35.9K | ﹤0.01% | 1847 |
|
|
2021
Q1 | $121K | Sell |
3,528
-1,627
| -32% | -$55.8K | ﹤0.01% | 2052 |
|
|
2020
Q4 | $180K | Buy |
5,155
+4,177
| +427% | +$146K | ﹤0.01% | 1917 |
|
|
2020
Q3 | $23K | Hold |
978
| – | – | ﹤0.01% | 2470 |
|
|
2020
Q2 | $18K | Hold |
978
| – | – | ﹤0.01% | 2474 |
|
|
2020
Q1 | $15K | Hold |
978
| – | – | ﹤0.01% | 2414 |
|
|
2019
Q4 | $21K | Hold |
978
| – | – | ﹤0.01% | 2492 |
|
|
2019
Q3 | $18K | Hold |
978
| – | – | ﹤0.01% | 2476 |
|
|
2019
Q2 | $26K | Hold |
978
| – | – | ﹤0.01% | 2380 |
|
|
2019
Q1 | $25K | Sell |
978
-892
| -48% | -$22.8K | ﹤0.01% | 2351 |
|
|
2018
Q4 | $43K | Hold |
1,870
| – | – | ﹤0.01% | 2127 |
|
|
2018
Q3 | $60K | Buy |
1,870
+605
| +48% | +$19.4K | ﹤0.01% | 2048 |
|
|
2018
Q2 | $36K | Buy |
+1,265
| New | +$36K | ﹤0.01% | 2287 |
|